I
Iain Stephenson
Researcher at University Hospitals of Leicester NHS Trust
Publications - 66
Citations - 5108
Iain Stephenson is an academic researcher from University Hospitals of Leicester NHS Trust. The author has contributed to research in topics: Vaccination & Influenza A virus. The author has an hindex of 31, co-authored 62 publications receiving 4891 citations. Previous affiliations of Iain Stephenson include University of Leicester & National Health Service.
Papers
More filters
Journal ArticleDOI
Transmission of Equine Influenza Virus to Dogs
P.C. Crawford,Edward J. Dubovi,William L. Castleman,Iain Stephenson,E. P. J. Gibbs,Li-Mei Chen,Catherine K. Smith,Richard C. Hill,Pamela J. Ferro,Justine Pompey,Rick A. Bright,Marie-Jo Medina,Calvin M. Johnson,Christopher W. Olsen,Nancy J. Cox,Alexander Klimov,Jacqueline M. Katz,Ruben O. Donis +17 more
TL;DR: The geographic expansion of the infection and its persistence for several years indicate efficient transmission of canine influenza virus among greyhounds, and evidence of infection in pet dogs suggests that this infection may also become enzootic in this population.
Journal ArticleDOI
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine : a randomised trial of two potential vaccines against H5N1 influenza
Karl G. Nicholson,Anthony Colegate,Audino Podda,Iain Stephenson,John Wood,Ellen Ypma,Maria Zambon +6 more
TL;DR: Addition of MF59 to A/Duck/Singapore/97 vaccines boost the antibody response to protection levels, and these findings have implications for development and assessment of vaccines for future pandemics.
Journal ArticleDOI
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.
Tristan W Clark,Manish Pareek,Katja Hoschler,Helen Dillon,Karl G. Nicholson,Nicola Groth,Iain Stephenson +6 more
TL;DR: Monovalent 2009 influenza A (H1N1) MF59-adjuvanted vaccine generates antibody responses likely to be associated with protection after a single dose is administered.
Journal ArticleDOI
Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy
Iain Stephenson,Iain Stephenson,Roberto Bugarini,Karl G. Nicholson,Audino Podda,John Wood,Maria Zambon,Jacqueline M. Katz +7 more
TL;DR: Human serum samples after immunization with MF59 or nonadjuvanted A/duck/Singapore/97 (H5N3) vaccine were tested for antibody to 1997-2004 human H5N1 viruses and findings have implications for the rational design of pandemic vaccines against influenza H5.
Journal ArticleDOI
Human metapneumovirus as a cause of community-acquired respiratory illness
TL;DR: HMPV appears to be associated with community-acquired ARTI, and the extent of illness and possible complications related to this new human virus need to be clarified.